Intellia Therapeutics, Inc. (NTLA)
12.55
-0.29
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
12.55
0.00 (0.00%)
After-Hours: 19:54
Intellia Therapeutics Total Assets (Quarterly) : 857.16M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 857.16M |
| March 31, 2026 | 758.78M |
| December 31, 2025 | 842.13M |
| September 30, 2025 | 925.28M |
| June 30, 2025 | 898.89M |
| March 31, 2025 | 986.16M |
| December 31, 2024 | 1.191B |
| September 30, 2024 | 1.173B |
| June 30, 2024 | 1.192B |
| March 31, 2024 | 1.260B |
| December 31, 2023 | 1.301B |
| September 30, 2023 | 1.243B |
| June 30, 2023 | 1.323B |
| March 31, 2023 | 1.418B |
| December 31, 2022 | 1.520B |
| September 30, 2022 | 1.084B |
| June 30, 2022 | 1.110B |
| March 31, 2022 | 1.203B |
| December 31, 2021 | 1.294B |
| September 30, 2021 | 1.335B |
| June 30, 2021 | 672.24M |
| Date | Value |
|---|---|
| March 31, 2021 | 716.89M |
| December 31, 2020 | 676.32M |
| September 30, 2020 | 458.56M |
| June 30, 2020 | 490.83M |
| March 31, 2020 | 314.75M |
| December 31, 2019 | 334.28M |
| September 30, 2019 | 346.64M |
| June 30, 2019 | 352.44M |
| March 31, 2019 | 344.36M |
| December 31, 2018 | 347.32M |
| September 30, 2018 | 321.23M |
| June 30, 2018 | 339.78M |
| March 31, 2018 | 359.54M |
| December 31, 2017 | 376.24M |
| September 30, 2017 | 249.17M |
| June 30, 2017 | 264.98M |
| March 31, 2017 | 279.26M |
| December 31, 2016 | 298.97M |
| September 30, 2016 | 301.47M |
| June 30, 2016 | 310.62M |
| March 31, 2016 | 75.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.386B |
| Twist Bioscience Corp. | 672.44M |
| Tenaya Therapeutics, Inc. | 93.54M |
| Moderna, Inc. | 10.96B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 129.46M |
| Shareholders Equity (Quarterly) | 727.71M |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 6.648 |
| Net Debt Paydown Yield | 0.39% |